EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and In Vitro Evaluation of the Anticancer Effect of Novel Phosphonium Vindoline Derivatives

Mónika Halmai, Viktória Donkó-Tóth, Péter Keglevich, Károly Kánai iD, Márton Weber, Miklós Dékány, Ejlal A Abdallah iD, Noémi Bózsity iD, István Zupkó iD, Andrea Nehr-Majoros, Éva Szőke, Zsuzsanna Helyes und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mónika Halmai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Mű…. Hauptthemen laut MEDLINE: Organophosphorus Compounds, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, National Research Development and Innovation Fund of the Ministry of Culture and Innovation, Hungarian Research Network (HUN-REN) Chronic Pain Research Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Vinca alkaloid vindoline was coupled at position 17 with several trisubstituted phosphine derivatives and their in vitro anticancer activities on 60 human tumor cell lines (NCI60) were investigated. This phosphonium-type ionic side chain is beneficial because it allows therapeutic molecules to pass through the cell membrane. Thus, the candidates coupled to it can exert their activities in the mitochondria. The coupling of vindoline with the trisubstituted phosphines was achieved through flexible or rigid linkers. Instead of the ionic phosphonium structural part, a neutral moiety, namely the triphenylmethyl group, was also added to the side chain, being sterically similar but without a charge and phosphorus atom. In addition, the triphenylphosphine element was also built at position 10 of vindoline. Most of the derivatives showed low micromolar growth inhibition (GI50) values against most cell lines. Among them, conjugate 9e was outstanding: it exhibited nanomolar anticancer activity on the RPMI-8226 leukemia cell line (GI50 = 20.0 nM). Compound 9g elicited cell cycle disturbance and apoptosis on A2780 ovary cancer cells and inhibited their migration at subantiproliferative concentrations. The selectivity of the conjugates was determined by their effects on non-tumor Chinese hamster ovary (CHO) cells in the CellTiter-Glo Luminescent Cell Viability Assay. Compound 9e showed an estimated half-maximal inhibitory concentration (IC50) value of 1.36 µM, suggesting good selectivity on cancer cells. These results open new perspectives of novel phosphonium-based vindoline derivatives as anticancer compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organophosphorus CompoundsAntineoplastic AgentsHumansCell Line, TumorApoptosisCell ProliferationAnimalsCricetulusCell CycleCHO CellsCell MovementPhosphinesCell SurvivalDrug Screening Assays, AntitumorStructure-Activity Relationship

Stichwörter der Autor:innen

anticancer effectcell viabilityphosphonium saltstriphenylphosphinevindoline

Substanzen

Organophosphorus CompoundsAntineoplastic AgentsPhosphines

Autor:innen und Institutionen

  • Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary.
  • Spectroscopic Research Department, Gedeon Richter Plc., Gyömrői út 19-21, H-1103 Budapest, Hungary.
  • Institute of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
  • Department of Pharmacology and Pharmacotherapy, Medical School & Centre for Neuroscience, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary.
  • National Laboratory for Drug Research and Development, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.
  • HUN-REN PTE Chronic Pain Research Group, Szigeti út 12, H-7624 Pécs, Hungary.

ORCID-Profile: Károly Kánai, Ejlal A Abdallah, Noémi Bózsity, István Zupkó

Förderung

  • European Union
  • National Research Development and Innovation Fund of the Ministry of Culture and Innovation
  • Hungarian Research Network (HUN-REN) Chronic Pain Research Group
  • Hungarian National Science and Research Fund
  • Ministry of Culture and Innovation of Hungary

Zitieren

APA

Halmai, M., Donkó-Tóth, V., Keglevich, P., Kánai, K., Weber, M., Dékány, M., Abdallah, E. A., Bózsity, N., Zupkó, I., Nehr-Majoros, A., Szőke, É., Helyes, Z., & Hazai, L. (2025). Synthesis and In Vitro Evaluation of the Anticancer Effect of Novel Phosphonium Vindoline Derivatives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083775

Vancouver

Halmai M, Donkó-Tóth V, Keglevich P, Kánai K, Weber M, Dékány M, et al. Synthesis and In Vitro Evaluation of the Anticancer Effect of Novel Phosphonium Vindoline Derivatives. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083775

BibTeX
@article{Halmai2025,
  author = {Halmai, Mónika and Donkó-Tóth, Viktória and Keglevich, Péter and Kánai, Károly and Weber, Márton and Dékány, Miklós and Abdallah, Ejlal A and Bózsity, Noémi and Zupkó, István and Nehr-Majoros, Andrea and Szőke, Éva and Helyes, Zsuzsanna and Hazai, László},
  title = {Synthesis and In Vitro Evaluation of the Anticancer Effect of Novel Phosphonium Vindoline Derivatives},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083775}
}
Kostenlos starten →